Document is current
Any future updates will be listed below
-
Authors
Bishop, Alena L. http://orcid.org/0000-0001-7189-015X
López Del Amo, Víctor http://orcid.org/0000-0002-5567-3072
Okamoto, Emily M.
Bodai, Zsolt
Komor, Alexis C. http://orcid.org/0000-0001-5043-0998
Gantz, Valentino M. http://orcid.org/0000-0003-2453-0711
-
Funding
Funding for this research was provided by:
National Science Foundation (MCB-2048207)
U.S. Department of Health & Human Services | NIH | NIH Office of the Director (DP5OD023098)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R01AI162911)
- License Information
-
More Information
Article History
Received: 21 September 2021
Accepted: 28 February 2022
First Online: 9 May 2022
Competing interests
: V.M.G. is a founder of and has equity interests in Synbal, Inc. and Agragene, Inc., companies that may potentially benefit from the research results described in this manuscript. V.M.G. also serves on both the company’s Scientific Advisory Board and the Board of Directors of Synbal, Inc. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. A.C.K. is a member of the SAB of Pairwise Plants, and is an equity holder for Pairwise Plants and Beam Therapeutics. A.C.K.’s interests have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. A.L.B., V.L.D.A., E.O., and Z.B. declare no competing interests.
